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aim of this study was to evaluate the functional and histological effects of bone marrow stem
cells (BMSC) combined with polyglycolic acid tube (PGAt) in autografted rat facial nerves. After
neurotmesis of the mandibular branch of the rat facial nerve, surgical repair consisted of nerve
autografting (groups A–E) contained in pGAT (groups B–E), ﬁlled with basement membrane
matrix (groups C–E) with undifferentiated BMSC (group D) or Schwann-like cells that had
differentiated from BMSC (group E). Axon morphometrics and an objective compound muscle
action potentials (CMAP) analysis were conducted. Immunoﬂuorescence assays were carried
out with Schwann cell marker S100 and anti-β-galactosidase to label exogenous cells. Six weeks
after surgery, animals from either cell-containing group had mean CMAP amplitudes signiﬁ-
cantly higher than control groups. Differently from other groups, facial nerves with Schwann-
like cell implants had mean axonal densities within reference values. This same group had the
highest mean axonal diameter in distal segments. We observed expression of the reporter gene
lacZ in nerve cells in the graft and distally from it in groups D and E. Group-E cells had lacZ
coexpressed with S100. In conclusion, regeneration of the facial nerve was improved by BMSC
within PGAt in rats, yet Schwann-like cells were associated with superior effects. Accordingly,
groups D and E had BMSC integrated in neural tissue with maintenance of former cell
phenotype for six weeks.
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Post-traumatic peripheral facial palsy is a debilitating condi-
tion with an increasing prevalence due to the high frequency
of accidents and violence in modern life leading to facial
asymmetry, impacting eye and oral motor functions, self-
esteem and mood (Bento et al., 1985). Restoration of function
after transection and repair of the facial nerve is still poor,
leading to residual paralysis, sinkinesis and hypotonia (Bento
and Miniti, 1993; Ferreira et al., 1994). Trauma and tumor
surgical resection may result in extensive nerve damage,
requiring repair by autologous nerve interposition grafting
or tubulization (Da-Silva et al., 1987; Bento and Miniti, 1989),
but full functional recovery is seldom achieved.
Nerve repair requires a complex interaction among a scaf-
fold for axonal growth guidance, supportive cells such as
Schwann cells, growth factors, and extracellular matrix (Da-
Silva et al., 1985; Costa et al., 2006; Costa et al., 2009a). The
combination of axonal scaffolds and transplanted cells provides
adequate support for neural regeneration, and has been inves-
tigated as a strategy to overreach the limitations of surgical
repair (Evans et al., 2002; Cheng and Chen, 2002; Udina et al.,
2004; Rodrigues et al., 2012). In particular, the polyglycolic acid
tube (PGAt), composed of absorbable material, has been estab-
lished as an appropriate conduit for nerve grafting, and has
been approved by the Food and Drug Administration (FDA, USA)
for use in the clinical setting (Mackinnon and Dellon, 1986; Da-
Silva et al., 1987; Mackinnon and Dellon, 1990; Weber et al.,
2000; Costa et al., 2006; Costa et al., 2009b; Schlosshauer et al.,
2006; Nectow et al., 2011).
Isolated and cultured Schwann or stem cells have been
employed in the surgical repair of the peripheral nerve (Dezawa
et al., 2001; Cuevas et al., 2002; Evans et al., 2002; Fansa and
Keilhoff, 2004; Udina et al., 2004; McKenzie et al., 2006; Chen
et al., 2007; Lavdas et al., 2008; Ishikawa et al., 2009; Wang et al.,
2009; Wakao et al., 2010; Wei et al., 2010; Ladak et al., 2011;
Wang et al., 2011; Rodrigues et al., 2012; Salomone et al., 2013).
Schwann-like cells have been reported to differentiate in vitro
from bone marrow stroma mesenchymal stem cells (BMSC)
primarily cultured from rat femurs (Dezawa et al., 2001; Chen
et al., 2007). Schwann-like cells experimentally employed in
peripheral nerve repair have improved myelination (Dezawa
et al., 2001; Cuevas et al., 2002; Chen et al., 2007; Ishikawa et al.,
2009; Wang et al., 2011). Although there are limited data on the
association of PGAt and genetically modiﬁed BMSC-derived
Schwann-like cells in the repair of the facial nerve (Shi et al.,
2009), a thorough, objective analysis on the functional nerve
recovery and of in vivo cell survival is lacking.
Our approach in the current study has been to employ the
gold-standard nerve repair procedure, nerve autografting,
combined to bone marrow mesenchymal stem cells seeded
in puriﬁed basement membrane as a secondary scaffold, used
to ﬁll the lumen of PGAt. Our aims were to compare the facial
nerve functional and morphological outcomes, and to evalu-
ate the presence and phenotype of the exogenous cells in the
autografted nerve, six weeks after implantation.
The use of ﬁve different animal groups allowed for
progressive addition of each component to be tested.
An objective comparison was performed to assess compoundmuscle action potential (CMAP) and axonal morphometry
variables. We disclose the highest CMAP amplitudes and
axonal diameters in the Schwann-like cell autografted
group. Our study also reveals unprecedented results on the
in vivo maintenance of the stem cells for six weeks in the
nerve tissue, which may be related to the superior character-
istics of the conduit and extracellular membrane components
employed.2. Results
Prior to surgery, lentivirus-transduced BMSC (BMSClacZþ)
obtained in vitro reacted positively in the colorimetric assay
for lacZ activity, whereas untransduced BMSC did not (Fig. 1,
A and B). BMSClacZþ differentiated in vitro in cells that were
immunostained for beta-galactosidase (Fig. 1, D, G and J),
presented thin and long cell processes (Fig. 1, H and K,
arrows), and expressed the cell markers S100, p75NTR and
Oct6 in the nucleus and cytoplasm (Fig. 1, C, F and I) that were
undetectable in undifferentiated cells.
At surgery, three animals from group E died most likely
due to hypersensitivity to anesthesia maintenance. On the
second day of the postsurgical period, one animal from group
D died due to unexplained cause. Data that had been
previously obtained for these animals were not considered
in this study.
2.1. Signiﬁcant improvement of CMAP amplitude
associated with cell implants
Data analyses using the Kruskal–Wallis test disclosed no
difference among groups regarding CMAP amplitude or
latency prior to neurotmesis and three weeks after surgery
(Fig. 2A). On the other hand, CMAP amplitude analyses made
in the six-week postsurgical point revealed differences
among the ﬁve groups (0.74 mA, 0.76 mA, 0.99 mA, 1.96 mA,
2.73 mA, respectively for groups A, B, C, D and E; po0.001,
Fig. 2A). Assessment by the Mann–Whitney test adjusted by
the Bonferroni coefﬁcient (alpha¼0.005116) disclosed a dif-
ference between any control group without Matrigels (A or B)
and any group of cell-containing Matrigels (D or E): p¼0.004
for each comparison, A vs. D; A vs. E; B vs. D; and B vs. E
(Fig. 2A). Other possible paired comparisons were not
signiﬁcant. These data indicate that CMAP amplitude is sig-
niﬁcantly higher for groups D and E six weeks after surgery.
At the sixth week, groups D and E presented respectively 44.52%
and 72.03% of their pre-injury CMAP amplitude values, whereas
groups A, B and C had the ratios of 12.8%, 15.94% and 16.98% in
the same period (Fig. 2A). Therefore, some functional recovery
has been observed for each study group.
2.2. Exogenous cells are maintained in vivo six weeks
after surgery
Qualitative histological analyses at the optical microscope of
segments proximal and distal to the graft revealed that, in
study groups A through D, the facial nerve has been reorga-
nized in one to three fascicles in the distal segment, whereas
group-E animals had the injured facial nerve reorganized in
Fig. 1 – In vitro treatment of BMSC yields cells with Schwann cell phenotype. Undifferentiated BMSC (A) and BMSClacZþ (B)
cells were submitted to colorimetric assay for the reporter gene activity. Blue color (B) denotes positive reaction for the
digestion of the X-Gal substrate by beta-galactosidase under oxidized conditions, only in cells that had been infected with
the lentivirus carrying the reporter gene (B). (C–K) BMSClacZþ submitted to differentiation in Schwann-like cells were
analyzed by confocal microscopy after indirect immunofluorescence, detecting double labeling of cells by the anti-beta-
galactosidase antibody (green, D, E, G, H, J and K) and antibodies detecting, in red, either S100 (C and E), p75NTR (F and H) or
Oct-6 (I and K). Arrows (H and K) indicate cell processes suggestive of Schwann-like cell differentiation. Nuclear staining is
indicated by arrowheads (F and I). Scale bars: 25 μm (C–K) and 50 μm (A, B).
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Fig. 2 – Animals that received cell implants reveal mean
CMAP amplitude and axonal density closer to uninjured
nerve values. (A) Bar graph representing the mean CMAP
amplitude and standard deviation for each group (A–E)
before neurotmesis and three and six weeks after surgery.
(B) Quantification of axonal density (three different fields
were counted for each animal from each group, A, B, C, D or
E and for the N group) in proximal and distal segments, as
shown. Data are presented as mean values and standard
deviation. Statistical significance (po0.05) according to the
Wilcoxon test for paired comparisons between proximal
and distal segments within groups is indicated by (*).
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surrounded by epineurium with fusiform cells. Mild reactive
tissue inﬁltrate has been observed in all groups, though
seemingly more intense in groups A and B. In all ﬁve groups,
nerve ﬁber sprouting has been identiﬁed outside the epineur-
ium limits. Group-A and -B facial nerves presented axons
with varying degrees of irregular, thin myelination, and many
Schwann cells with dense, small nuclei, and inconsistent
sizes. In groups D and E, axons had apparently a more
unifying shape and regular, thicker myelin sheath than in
groups A and B. Perineural space was wider in groups A and B
than in groups D and E. Group C had reactive tissue and
axonal phenotype of intermediate intensities between those
observed for control groups (A and B) and for the cell therapy
groups (D and E).Nerve sections from groups C (control), D and E have been
submitted to immunoﬂuorescence assay with antibodies
anti-S100 as a Schwann cell marker and anti-β-galactosidase
to label exogenous BMSC cells or Schwann-like cells derived
in vitro from these. All sections have been stained for S100 as
an endogenous marker, deﬁning the nerve fascicle limits
(Figs. 4 and 5). No staining for β-galactosidase has been
observed for group C (Figs. 4 and 5, B and C). Nerve sections
within the grafting (proximal segment) and distal to it (distal
segment) have been analyzed from groups D and E. Appar-
ently more β-galactosidase-positive cells have been observed
in proximal sections (Fig. 4 E and H) than in distal segments
(Fig. 4 K and N) from group D. In this group, no double
labeling with anti-S100 antibody has been identiﬁed (Fig. 4F, I,
L and O). Group E had seemingly fewer cells labeled for
β-galactosidase than group D. In addition, group-E proximal
segments had nearly half of β-galactosidase-stained cells
doubly labeled for S100 (Fig. 5F, arrowheads), whereas co-
labeling in distal segments was less frequent though sugges-
tive in some cells (Fig. 5G, H and I, arrows). Double labeling
refers to the same cell labeled by both antibodies, and not
necessarily subcellular colocalization.2.3. Facial nerve axonal diameter increases in Schwann-
like cell-treated animals
In the present study, quantitative histological analyses
yielded axonal density for nerve sections within the graft
and distal to it. The axonal density comparison disclosed
signiﬁcant reductions in groups A through D in distal sections
compared to proximal segments, as seen by the Wilcoxon test,
with p-values of 0.028, 0.028, 0.024, and 0.018 respectively for
groups A (0.275 vs. 0.214), B (0.269 vs. 0.171), C (0.243 vs. 0.208)
and D (0.2 vs. 0.151). No signiﬁcant difference has been
observed for group E (0.216 vs. 0.172, p¼0.074) between
proximal and distal segments (Fig. 2B). In addition, for each
group, the normal distribution of axonal density within a
95%-conﬁdence interval was compared to group N mean
axonal density for either proximal or distal segments.
For proximal segments, mean axonal density for group N
(0.19) was similar to either group D or E (0.181–0.219 and
0.173–0.260, respectively); and for distal segments, mean
axonal density for group N (0.18) was not discordant from
groups B or E (0.145–0.197 and 0.134–0.210, respectively).
Using the Mann–Whitney test, adjusted by the Bonferroni
coefﬁcient (alpha¼0.005116), axonal density for group-D
proximal sections of facial nerve showed to be lower than
those for proximal sections from groups A (p¼0.003), B
(p¼0.003), and C (p¼0.004). Similarly, group D presented
the lowest axonal density for distal sections of the nerve,
which was signiﬁcantly different from groups A and C (Mann–
Whitney test, Bonferroni alpha coefﬁcient: 0.005116; p¼0.003
and p¼0.004, respectively).
Myelinated axons in distal sections (1939, 2160, 1468, 1763
and 2108 axons measured from groups A, B, C, D and E,
respectively) had their diameter estimated in each shortest
external extension (Fig. 3). Groups A through E presented
increasing mean axonal diameters (respectively, 2.17 μm,
2.13 μm, 2.73 μm, 3.07 μm, and 3.59 μm). Group N (1871
Fig. 3 – Schwann-like cells are associated with increased facial nerve axonal diameters. (A) Representative optical microscopy
images of semi-thin cross-sections of facial nerve segments positioned distally to the grafting. Images are after toluidine
blue staining of sections from groups N, A, B, C, D and E, as indicated. Scale bars: 20 μm. (B) Graph representing the axonal
diameter of facial nerve distal segments from groups A–E and group N. Data are presented as mean values with standard
deviation. All comparisons, except for A vs. B, disclosed significant results (po0.001, according to Mann–Whitney test).
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4.99. Groups A and B presented similar axonal diameters
(Mann–Whitney test, adjusted by the Bonferroni coefﬁcient,
alpha¼0.003414; p¼0.567). On the other hand, all other
possible comparisons presented po0.001. Therefore, we
may conclude that, six weeks after surgery, group-E facial
nerves presented the largest axonal diameter, followed by
that from group D.3. Discussion
Schwann cells are glial cells of the peripheral nervous
system, surrounding the axon and facilitating the conduction
of the nervous impulse. In Wallerian axonal degeneration,
Schwann cells, along with macrophages, mediate the initial
steps for myelin removal. Schwann cells proliferate, migrate
to form the Büngner bands, and secrete neurotrophic
factors that aid axonal guidance and to establish a favorable
Fig. 4 – BMSC cells expressing β-galactosidase in autografted facial nerves are negative for the Schwann cell marker S100.
Nerve sections have been submitted to indirect immunofluorescence assays with anti-S100 (green) and anti-β-galactosidase
(red) antibodies, as indicated. Overlapping images for verification of double staining of cells are shown on the right column.
Groups C and D sections are shown. Images G–I and M–O are a two-fold zoom of D–F and J–L images, respectively. Few
β-galactosidase-positive cells in distal segments are clearly negative for S100 (arrowheads), even when located within a
nerve fascicle. Scale bars: 50 μm (except for G–I and M–O, 100 μm).
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et al., 2003). However, there are inherent limitations in their
direct use in the experimental nerve repair, as those cells come
from restricted sources and have limited availability (Fansa and
Keilhoff, 2004; Wei et al., 2010).Several works have provided evidence that stem cells may
replace Schwann cells in that endeavor through in vivo or
prior in vitro Schwann cell differentiation (Dezawa et al., 2001;
Cuevas et al., 2002; Evans et al., 2002; Caddick et al., 2006;
McKenzie et al., 2006; Chen et al., 2007; Mahay et al., 2008;
Fig. 5 – Group-E facial nerve sections contain cells that express the Schwann cell marker S100 and the bacterial reporter
protein β-galactosidase. Facial nerve sections within the grafting (proximal segment) and distal to it (distal segment) were
submitted to immunofluorescence analyses for detection of S100 (Schwann cell marker, green) or β-galactosidase (gene
reporter expression, red). Double staining suggestive of exogenous Schwann-like cell integration in the nerve is indicated
(F, arrowhead) for proximal segment. In distal segment, one cell stained for β-galactosidase (H, arrow) seems to be labeled
faintly by S100 (G, arrow), suggestive of Schwann-like cell distally to the grafting (I, arrow). Scale bars: 100 μm (except for the
control group C, images A–C, 50 μm).
b r a i n r e s e a r c h 1 5 1 0 ( 2 0 1 3 ) 1 0 – 2 116Ishikawa et al., 2009; Wang et al., 2009; Wakao et al., 2010;
Wei et al., 2010; Ladak et al., 2011; Wang et al., 2011;
Salomone et al., 2013). BMSC in the surgical repair of periph-
eral nerves have improved axonal regeneration and func-
tional recovery (Dezawa et al., 2001; Cuevas et al., 2002; Chen
et al., 2007; Ishikawa et al., 2009; Wang et al., 2009; 2011;
Salomone et al., 2013) that is related to their capability to
secrete trophic factors besides Schwann cell The nuclear
distribution of p75NTR and Oct-6, as reported for cells in the
present study, is consistent with a phenotype for Schwann
cells. The in vivo expression of the transcription factor Oct-6 is
an important feature favoring axon myelination (Sim et al.,
2002; Jaegle et al., 2003). Also, myelin formation is inhibited in
the absence of functional p75NTR (Cosgaya et al., 2002).
The nuclear localization of p75NTR has been shown to be
mediated by its intracellular domain upon cleavage by
γ–secretase, and associated with gene transcription regulation
(Parkhurst et al., 2010). Therefore, as we report in Fig. 1, p75NTR
and Oct-6 expression and subcellular distribution corroborate
the Schwann-like cell phenotype (Dezawa et al., 2001; Jessen
and Mirsky, 2005). In addition, the expression of S-100 proteinhas been associated with myelin synthesis in vivo (Mata et al.,
1990). Therefore, the relatively low in vitro expression of S-100 as
compared to p75NTR and Oct-6, in Fig. 1, may be related to a
more immature phenotype of the cells examined in vitro.
In the present study, the autologous nerve interposition
grafting was used as the control group (group A) since it is the
gold-standard procedure for nerve injury repair in the clinical
practice. Other groups (B–E) contained resources that could
potentially improve nerve regeneration, such as PGAt, Matri-
gels (groups C–E), and undifferentiated BMSC (group D) or
Schwann-like cells differentiated from BMSC (group E). Our
analyses revealed no signiﬁcant improvement of any variable
for the association of nerve grafting (group A) with PGAt
(group B) or with PGAt plus basement membrane matrix
(group C). Following neurotmesis and surgical repair, the
improvement of CMAP amplitude values was remarkable
(72%) in a six-week period for Schwann-like cells group
(group E). Additionally, group E had similar axonal densities
for proximal and distal nerve segments and the highest axonal
diameter among treated groups. In Schmalbruch (1986) report,
axonal diameter was disclosed as the best morphological
b r a i n r e s e a r c h 1 5 1 0 ( 2 0 1 3 ) 1 0 – 2 1 17outcome variable for nerve regeneration. In addition, data from
Titmus and Faber (1990) have directly supported the axonal
diameter as a reliable variable for nerve regeneration and
function, due to its direct relationship with the nerve conduc-
tion speed and the probability for appropriate target organ
innervation. Importantly, the employment of electromyography
in our study as standardized by Salomone et al. (2012) has
allowed a very sensitive and objective analysis of the facial
nerve function. Therefore, group E functional outcome was
remarkably corroborated by its morphometric data.
The ﬁnding of similar axonal density between proximal
and distal segments in group E may also infer more appro-
priate target innervation of the facial nerve that received the
Schwann-like cell implants, as also observed by Guntinas-
Lichius et al. (2005). In contrast, increased axonal density in
both segments from control group (A, B and C) facial nerves
may indicate axonal sprouting that is likely to be coupled
with multiple, ineffective innervations. On the other hand, in
those groups, at the sixth week after surgery the functional
analyses unveiled CMAP amplitudes that varied between 13%
and 17% of their pre-injury values. These results are compa-
tible with some regenerative outcome from autografting with
or without PGAt or basement membrane, which are in
agreement with the standards from the clinical practice.
Our analyses reveal a gap between control groups A–C and
Schwann-like cell-containing group E. Standing between are the
results from group D, which contained implants of undifferen-
tiated BMSC. Six weeks after surgery, group D had mean CMAP
amplitude signiﬁcantly higher than those from groups A or B.
It represented 45% of its pre-injury data. Group D morphological
data unraveled increased axonal diameter though signiﬁcantly
shorter than that from group E. Therefore, we may also conclude
that undifferentiated BMSC associated with nerve grafting and
PGAt conduit has amore satisfying functional andmorphological
outcome for the injured facial nerve than the same surgical
procedure without cell implant. Nevertheless, group E data
remained superior and more consistent than those from group
D in all aspects evaluated.
Our data are in agreement with others that demonstrated
the beneﬁcial effects of BMSC in the surgical repair of the lesion
of peripheral nerves (Dezawa, 2001; McKenzie et al., 2006;
Ishikawa et al., 2009; Wang et al., 2009; Wakao et al., 2010;
Ladak et al., 2011; Wang et al., 2011; Salomone et al., 2013).
Moreover, studies approaching speciﬁcally the facial nerve have
been reported. Satar et al. (2009) observed better axonal orga-
nization and higher myelin thickness in facial nerves repaired
by the addition of BMSC. Salomone et al. (2013) employed cell
implants contained in a silicone conduit in nerves sutured from
isolated stumps without autografting. Our study and theirs
have used objective electromyographical analyses to function-
ally assess the nerve, and observed higher CMAP amplitude
values for both cell-containing groups, although their results
present a better outcome for BMSC. Wang et al. (2011) applied a
vein conduit without scaffold to repair the rabbit facial nerve
with BMSC or Schwann-like cells. Their study and ours report
the superior outcome of Schwann-like cells associated with
autografting.
The most important aspect for cell survival in the receptor
tissue is the microenvironment. Initially, tissue homing is
related to the cell expression of surface adhesion markersthat interact with components from the extracellular matrix.
This in addition to paracrine effects of growth factors
secreted from adjacent cells provides conditions for cell
survival, migration, tissue invasion and differentiation
(Caddick et al., 2006). Both cell types from our study, BMSC
and Schwann-like cells, should have succeeded in performing
those cell processes, as they have been observed in vivo six
weeks after their implant and also distally to the graft.
The in vitro differentiation of Schwann-like cells might have
empowered them with better conditions for nerve homing
and maintenance of the expression of the Schwann cell
phenotype for group-E cells. Since after the initial three
weeks of the postsurgical period no signiﬁcant functional
difference has been observed among or between groups, it is
possible that Schwann-like cells have increasingly acquired
more cellular activity that contributed to the superior out-
come of group-E animals at the six-week timepoint. More-
over, the early expression of some Schwann cell proteins is
likely to be related to the superior functional and morpholo-
gical results from this cell group, allowing long-acting effects
of Schwann-like cells or progressing from a Schwann cell-
committed phenotype to complete in vivo differentiation into
a mature Schwann cell. However, we may not exclude the
possibility of cell dedifferentiation and redifferentiation
in vivo upon nerve homing in group-E animals. Salomone
et al. (2013) observed higher CMAP amplitude for both BMSC
and Schwann-like cells; however, they could not identify the
cells in the tissue after the same period. This contrasts to our
data and it is possibly due to the use of a different conduit
composed of silicone. Therefore, the conduit nature should
have been determinant for the cell survival in our study.
Likewise, the vein conduit employed by Wang et al. (2011) has
not been detrimental to the survival of Schwann-like cells or
BMSC. However, the cells have been demonstrated in vivo
within the conduit but not within the nerve tissue. Conduits
direct axonal growth and allow higher concentration of
neurotrophins if the cells that provide them surround the
regenerating axons (Dellon, 1995; Lin and Marra, 2012). It has
been well established that synthetic tubes composed of
absorbable material associate with better functional outcome
at long term when compared to non-absorbable tubes
(Da-Silva et al., 1987), which may limit axonal regeneration
due to localized compression by the latter (Mackinnon and
Dellon, 1986). Besides, the absorbable conduits allow higher
concentration of growth factors and extracellular matrix
proteins surrounding the regenerating axons (Dellon, 1995;
Lin and Marra, 2012).
BMSC have been shown to consistently produce nerve
growth factor, brain-derived growth factor, glial cell line-
derived growth factor and ciliary neurotrophic factor in a
way related to nerve regeneration support (Chen et al., 2007;
Pittenger et al., 1999). Although the experimental design of
the work from Wang et al. (2009) did not comprehend in vivo
cell observation and an objective and sensitive analysis of the
nerve function such as described in the present work, in their
short period of observation (two weeks) they demonstrated
increased expression of neuronal cytoskeleton molecules
(GAP43, light chain neuroﬁlament) and growth factors (NGF
and BNDF) in nerves that had received BMSC in PGAt/
chitosan conduits. Therefore, growth factor secretion and
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molecules should be shaped by BMSC in the nerve regenera-
tion microenvironment. On the other hand, some reports on
nerve repair by Schwann-like cell implants reinforce the
better outcome of these cells (Shi et al., 2009, Cho et al.,
2010), although there has been no long-term veriﬁcation of
the presence of these cells within the nerve. The beneﬁts of
Schwann-like cells in nerve repair may now be more convin-
cingly explained by the long-lasting survival of the cells
in vivo.
Based on our results, it is likely that undifferentiated BMSC
did not differentiate in vivo into Schwann cells as hypothe-
sized by Jiang et al. (2002) but did assist endogenous cells by
improving their microenvironment towards a more regen-
erative one. We may infer that the permanence of Schwann-
like cells in the nerve tissue for six weeks has rendered them
physiologically more active. The expression of Schwann cell
markers in vivo suggests that the Schwann cell phenotype of
the exogenous cells is directly related to the superior and
functional outcomes of animals from group E, in a way
dependent on their long-term survival related to appropriate
extracellular matrix components as well as the conduit
employed in our study.4. Conclusion
In conclusion, this study reveals signiﬁcant improvement of
the regeneration of the facial nerve by basement membrane-
embedded bone marrow stem cells within polyglycolic acid
tube in rats. Yet, Schwann-like cells were associated with
superior functional and histological results. Bone marrow
stem cells and Schwann-like cells integrated and remained
in neural tissue for six weeks since implantation, with an
in vivo cell marker expression phenotype similar to the one
observed in vitro.5. Experimental procedures
5.1. Animals
Wistar rats were obtained from the animal facility of the
University of Sao Paulo Medical School. Research was con-
ducted in accordance with international standards for animal
care and experimentation after approval of the protocol by
the Institution Ethics Review Board. Thirty-ﬁve adult males,
weighing between 250 and 300 g, were used in experimental
surgery, and two extra rats were the donors of bone marrow.
Anesthesia for surgical procedures consisted of intramuscu-
lar injection of ketamine (4 mg/100 g) and xylazine (1 mg/
100 g). Animals received a single dose of intramuscular
penicillin G potassium (50,000 U/kg) in the immediate post-
surgical period. Sacriﬁces were by anesthetics overdose.
5.2. Vector and antibodies
Lentiviral vector plasmid LV-Lac was obtained from Addgene
(Cambridge, MA), and had the coding sequence for the
bacterial lacZ reporter gene. Primary antibodies were directedto beta-galactosidase (clone GAL-40, Sigma, St Louis MO),
S100 (Abcam, Cambridge MA), Oct-6 (Abcam, Cambridge MA)
and p75NTR (CD271, Abcam, Cambridge MA). Secondary
antibodies were conjugated to Alexa 488 or Alexa 568
(Life Technologies, Grand Island NY).5.3. Polyglycolic acid tube (PGAt)
GEM NeuroTubes is an absorbable woven polyglycolic acid
(PGA) mesh tube designed for single use in patients with a
peripheral nerve injury, leading to a tensionless repair. Due to
its composition, it lacks concerns regarding animal material
origin or foreign bodies. NeuroTubes, herein referred to as
PGA tube (PGAt) has corrugated walls being ﬂexible and
resistant to kinking or occlusive forces of surrounding tissue.
PGAt's mesh allows the inﬁltration of oxygen to support the
regeneration process, and is absorbed in the body via hydro-
lysis, beginning to break down at three months, and
reabsorbed within six to eight months from implantation.
No hydration or preparation of Neurotube is necessary prior
to surgery.5.4. Primary cell culture and lentiviral transduction
Primary culture of BMSC was according to Dezawa et al.
(2001). Brieﬂy, bone marrow was removed from two rat
femurs by injecting 10 mL of alpha-MEM culture medium
(Life Technologies, Carlsbad, CA) in the bone canal, allowing
immediate suspension of cells, which were cultured in alpha-
MEM, supplemented with fetal bovine serum (FBS) at 15%,
2 mM glutamine, and antibiotics (Life Technologies, Carlsbad,
CA). Cultures were incubated at 37 C, with 5% CO2. After 24 h,
non-adhered cells were removed and media replaced. Cells
were subcultured two times and frozen in complete medium
containing 10% DMSO (Azizi et al., 1998).
For virus production, HEK-293T cells were plated and
transfected by calcium phosphate with the lentiviral vector
plasmid and the packaging vectors psPAX2 and pCMV-VSVg
(Addgene). Virus supernatants were concentrated by ultra-
centrifugation, aliquoted and stored at −80 C. One X 105 BMSC
from passage 3 were transduced in suspension using LV-Lac
at a MOI (multiplicity of infection) of 1.9 and polybrene at
4 mg/mL in 500 mL of media. After 2 h, the suspension was
seeded in a 35 mm plate in 2 mL medium. This procedure was
reproduced in several plates. After 48 h of culture, control
cells were ﬁxed in 2% paraformaldehyde, 0.2% glutaraldehyde
in 100 mM sodium phosphate buffer, pH 7.3 for 5 min, 4 C and
stained in 1.2 mM MgCl2, 3 mM K3Fe(CN)6, 3 mM K4Fe(CN)6
and 1 mg/mL x-gal in 100 mM sodium phosphate buffer, pH
7.3 for 16 h at 37 C to reveal β-galactosidase activity.
Transduced cells were cryopreserved and denominated
BMSClacZþ. BMSClacZþ cells were expanded, harvested in
trypLE express (Invitrogen, Carlsbad, CA), 1 mM EDTA, resus-
pended in Matrigels (BD Biosciences, San Jose, CA) at
1–2107/mL, and kept on ice for a few minutes until the
surgical procedure.
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BMSC differentiation into Schwann-like cells was according to
Dezawa et al. (2001). BMSClacZþ cells were cultivated for ten
days in complete medium, which was replaced every 48 h. On
the tenth day, media was replaced by alpha-MEM, supplemen-
ted with sodium pyruvate to 1 mM, beta-mercaptoethanol
(Sigma, St Louis MO) to 1 mM, 2mM glutamine and antibiotics.
After 24 h, media was replaced by alpha-MEM, 2mM glutamine,
10% FBS, 35 ng/mL all-trans retinoic acid (Sigma, St Louis, MO),
and antibiotics, and maintained for 72 h. The cells were then
fed with alpha-MEM supplemented with 10% FBS, 5 μM forsko-
lin (Sigma, St Louis MO), 10 ng/mL basic ﬁbroblast growth factor
(bFGF, Peprotech, Rocky Hill, NJ), 5 ng/mL platelet-derived
growth factor AA (PDGF-AA, Peprotech, Rocky Hill, NJ),
200 ng/mL hergulin B1 epidermal growth factor (Peprotech,
Rocky Hill, NJ), and antibiotics for seven days, with media
changed every 48 h. BMSC cells submitted to full differentia-
tion protocol were ﬁxed in 4% paraformaldehyde for 20min at
37 1C. After washing in phosphate-buffered saline, cells were
analyzed by colorimetric assay for lacZ expression or indirect
immunoﬂuorescence for expression characterization of appro-
priate cell markers. The colorimetric assay was performed as
described above. General immunoﬂuorescence protocol was
according to Oiticica et al. (2010). Images were acquired in a
LSM410 confocal microscope (Zeiss, Germany).
5.6. Surgical procedure and study groups
Thirty-ﬁve rats were randomly distributed into ﬁve groups of
seven animals each, except for groups C and E that had
respectively six and eight animals. All animals from one
group were submitted to the surgical procedure on the same
day. As techniques differed as described below, surgeon was
not blinded to the study group. The surgery was carried out
under the magniﬁcation of 40 by the aid of a surgical
microscope (Carl Zeiss, Germany). Each animal was anesthe-
tized and had the mandibular branch of the left facial nerve
exposed and transected twice providing one 5-mm nerve
fragment, which was employed as the autograft by suturing it
with six isolate, epineural, stitches using nylon 10–0s mono-
ﬁlament and BV-7 needle (Ethicon, Johnson&Johnson, New
Brunswick, NJ) keeping previous orientation.
The ﬁve study groups, A through E, differed according to extra
surgical technique aiming at the facial nerve repair. Group-A
animals comprised the control group (autograft). For animals in
groups B through E, the autologous graft was involved in a PGAt
(GEM NeuroTubes, Synovis Micro, Birmingham AL), measuring
2.3mm (inner diameter) by 6mm (length). For this step, the
neurotube was placed surrounding the proximal stump, followed
by the suture of the graft and then the tube was slid towards the
graft and sutured to the perineural tissue with a single stitch
with nylon 10–0s monoﬁlament and BV-7 needle (Ethicon,
Johnson&Johnson, New Brunswick, NJ). Animals from groups C
through E had 200 μL of Matrigels (BD Biosciences, San Jose, CA)
disposed by a micropipet and sterile tip between the graft and
the neurotube after suturing. Groups D and E had cells in
Matrigels and consisted of the test groups. In group D, Matrigels
contained 4105 undifferentiated BMSClacZþ cells. Group-E
animals had in Matrigels 4105 BMSClacZþ cells that had beensubmitted to the full protocol for differentiation into Schwann-
like cells. In animals from groups C, D and E, the ends of the
PGAt were sealed with ﬁbrin-derived biologic glue (Evicels,
Ethicon, Johnson&Johnson, New Brunswick, NJ). A sixth group
(N) was composed of 22 rats that were not submitted to
neurotmesis or surgical repair but had two sections (proximal
and distal) of the mandibular branch of the facial nerve for
standardization of histological analyses (Costa et al. 2012,
unpublished).
5.7. Functional analyses
Functional analyses were performed at three time points: before
injuring the nerve, and three and six weeks after the surgical
procedure. Animals were deeply anesthetized with ketamine
and submitted to neurophysiological evaluation by electromyo-
graphy of the mandibular branch of the facial nerve aiming at
obtaining compoundmuscle action potentials (CMAPs). Outcome
variables were the CMAP amplitude and latency values.
To obtain the CMAPs, we used a portable electromyogra-
phy system (Neuro-MEP-Micros, Neurosoft, Dhaka, Bangla-
desh) connected to a battery-operated Pavilion dv5C portable
personal computer (Hewlett-Packard). The Neuro-MEP.NET
software (version 2.4.23.0, Neurosoft) was employed to assess
the CMAP data obtained under the following conﬁguration of
the electromyography system: 10-Hz high-pass ﬁlter, 10-kHz
low-pass ﬁlter, notch ﬁlter off, 60 mV of leading edge signal,
and 10-kHz of sampling rate. The electromyography protocol
has been established speciﬁcally for evaluation of the rat
facial nerve and described in detail by Salomone et al. (2012).5.8. Morphometric analyses
Histomorphometric analyses were performed blindly six
weeks after surgical procedure, and this method was well
established by Costa et al. (2006; 2007; 2012). After sacriﬁce,
the surgically repaired portion of the facial nerve was cut into
four parts, two distally and two proximally related to the
graft. One pair of proximal (middle of the autografting) and
distal (3 mm distal to autografting) sections was ﬁxed in 2%
glutaraldehyde and 1% paraformaldehyde in 0.0031 M phos-
phate buffer, pH 7.3. After 60 min. in solution A, the tissue
was postﬁxed for 2 h in 2% osmium tetroxide in phosphate
buffer, dehydrated in ethanol, inﬁltrated in propilene oxide
and included in Epoxis resin (Burlington, VT) until polymer-
ization. Transversal, 1-μm sections were made and stained
with 1% toluidine blue. Histological observations were carried
out using light microscopy (Nikon Eclipse E 600, Nikon,
Japan). The slides were photographed with a digital camera
(Nikon Coolpix E 955, Nikon, Japan), and cell measurement
taken (Sigma Scan Pro 5.0 software, SPSS Science). Qualitative
analyses were performed according to general nerve archi-
tecture, pattern of tissue organization and myelination.
For quantitative analyses of distal portion of the facial nerve,
axons were counted in a partial area of 9.000 μm2 in three
randommicroscopic ﬁelds for every ﬁber displaying its center
within it. Total axon density was obtained by the ratio
between total axon number and area. The shortest external
diameter (including the myelin sheath) of all axons within a
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section of the nerve was measured to evaluate the matura-
tion of myelinated ﬁbers (Mayhew and Sharma, 1984).
The second pair of proximal and distal sections was ﬁxed
in 4% paraformaldehyde in phosphate-buffered saline. After
ﬁxation for 24 h, the tissue was embedded in parafﬁn and
prepared for microscopy. Eight-μm sections were obtained in
an 820-II microtome (Reichert-Jung, Austria). Following xylol-
based parafﬁn removal and tissue rehydration, three
10-minute incubations in 3% hydrogen peroxide took place.
Immunoﬂuorescence assays followed standard protocols
(Oiticica et al., 2010). Images were obtained by confocal
microscopy (LSM510, Zeiss, Germany) after background sub-
traction from negative control (primary antibody omission).
5.9. Statistical analyses
The means obtained for CMAP amplitude and latency for each
group were analyzed by the Kruskal–Wallis test to determine if
there was any difference among groups. Group-paired analyses
for CMAP amplitude, segment axonal density or diameter were
performed with the Mann–Whitney test. Axonal density com-
parisons between different segments (proximal or distal) were by
the Wilcoxon (Mann–Whitney-U) test. All statistical analyses
were performed using the Statistical Package for Social Sciences
(SPSS, version 19.0). Signiﬁcance level was 5% (po0.05) unless
when adjusted by the Bonferroni coefﬁcient.Acknowledgments
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